Share chart Xilio Therapeutics, Inc.
Extended chart
Simple chart
About Xilio Therapeutics, Inc.
Xilio Therapeutics, Inc., биотехнологическая компания клинической стадии, открывает и разрабатывает иммуноонкологические методы лечения, активируемые опухолью. Его программа ингибиторов контрольных точек включает XTX101, экспериментальное Fc-усиленное, активируемое опухолью моноклональное антитело против CTLA-4, которое находится в фазе 1 клинических испытаний для пациентов с солидными опухолями на поздних стадиях. more details| IPO date | 2021-10-22 |
|---|---|
| ISIN | US98422T1007 |
| Industry | Biotechnology |
| Sector | Health Care |
| Валюта | usd |
| Валюта отчета | usd |
| Сайт | https://xiliotx.com |
| Цена ао | 0.733 |
| Change price per day: | 0% (0.709) |
|---|---|
| Change price per week: | +5.35% (0.673) |
| Change price per month: | -11.26% (0.799) |
| Change price per 3 month: | -35.55% (1.1) |
| Change price per half year: | -11.38% (0.8) |
| Change price per year: | -43.73% (1.26) |
| Change price per 3 year: | -89.77% (6.93) |
| Change price per year to date: | -24.41% (0.938) |
|
|
Underestimation
|
Efficiency
|
|||||||||||||||||||||||||||||||||||||
Dividends
|
Debt
|
Growth impulse
|
|||||||||||||||||||||||||||||||||||||
| Institutions | Volume | Share, % |
|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 2805413 | 8.14 |
| Atlas Venture Life Science Advisors, LLC | 2759344 | 8 |
| FMR, LLC | 1907671 | 5.53 |
| Octagon Capital Advisors LP | 1785000 | 5.18 |
| RiverVest Venture Management LLC | 1441444 | 4.18 |
| Rock Springs Capital Management, LP | 1440759 | 4.18 |
| Vanguard Group Inc | 902531 | 2.62 |
| Artal Group S.A. | 450000 | 1.31 |
| Trustees Of Columbia University In The City Of New York | 249635 | 0.72 |
| FIL LTD | 218705 | 0.63 |
| Head | Job title | Payment | Year of birth |
|---|---|---|---|
| Mr. Kevin M. Brennan | Senior VP of Finance & Accounting | N/A | 1970 (55 years) |
| Dr. Uli Bialucha Ph.D. | Chief Scientific Officer | N/A | |
| Mr. Christopher Frankenfield | Chief Operating Officer | N/A | 1982 (43 years) |
| Dr. Rene Russo BCPS, Pharm.D. | President, CEO & Director | 888.49k | 1975 (50 years) |
| Dr. Katarina Luptakova M.D. | Chief Medical Officer | N/A | 1976 (49 years) |
| Dr. Scott Coleman Ph.D. | Chief Development Officer | N/A |
Address: United States, Waltham. MA, 828 Winter Street - open in Google maps, open in Yandex maps
Website: https://xiliotx.com
Website: https://xiliotx.com
